In the News
OncLive
January 25, 2025
Balstilimab and botensilimab combination therapy showed superior efficacy in MSS mCRC patients without liver metastases compared to botensilimab monotherapy.
Manufacturing Today
December 20, 2024
Harnessing the power of the immune system, Agenus Bio leads the charge in immuno-oncology.
Onco Daily
July 13, 2024
The new issue of OncoDaily Magazine had the privilege to feature an exclusive interview with Dr. Benny Johnson, Senior Medical Director at Agenus, discussing his career and dedication to oncology, his motivation, professional vision for emerging treatments and personal experiences with cancer.
OncLive
July 1, 2024
Botensilimab and balstilimab demonstrated pathological responses across subsets of patients with resectable colon cancer.